Association of Maternal Residence with Failure to Detect Fetal Congenital Heart Disease

Diego A Trejo1, Ling Li2, Jeffrey A Robinson2

  • 1Department of Pediatrics, Children's Nebraska, 8200 Dodge Street, Omaha, NE, 68114, USA. diegotrejo01@gmail.com.

Pediatric Cardiology
|August 14, 2025
PubMed

False-negative screening for prenatal congenital (CHD) and critical congenital heart disease (CCHD) requiring early intervention may result in increased morbidity and mortality. The association between false-negative obstetric screening and maternal community population remains unclear. A retrospective review of prenatal and postnatal CHD diagnoses was performed at Children's Nebraska from January to December 2024. Maternal households and associated obstetric practices were designated rural or urban status using USDA Rural-Urban Continuum Codes (RUCC). Differences in prenatal CHD detection were compared between mothers and obstetricians in rural versus urban communities using chi-square analyses. Differences between rural and urban maternal residency for postnatally diagnosed CHD versus CCHD were also evaluated. A total of 247 cases were analyzed, including 180 fetuses diagnosed prenatally and 67 infants diagnosed postnatally. Rural maternal residency was significantly associated with a higher rate of failure to detect prenatal CHD, χ2 (1, n = 247) = 6.10, p = 0.013. There was no statistically significant association between maternal geography, χ2 (1, n = 67) = 0.02, p = 0.894, or location of obstetric services with prenatal diagnosis of CCHD, χ2 (1, n = 194) = 0.65, p = 0.420. Prenatal CHD detection is significantly lower among infants born to mothers residing in rural communities, placing these infants at increased risk for delayed diagnosis and subsequent postnatal cardiac complications. These findings highlight the need for targeted strategies to improve prenatal cardiac screening in underserved areas.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57